Cargando…
Restoring the balance: immunotherapeutic combinations for autoimmune disease
Autoimmunity occurs when T cells, B cells or both are inappropriately activated, resulting in damage to one or more organ systems. Normally, high-affinity self-reactive T and B cells are eliminated in the thymus and bone marrow through a process known as central immune tolerance. However, low-affini...
Autores principales: | Smilek, Dawn E., Ehlers, Mario R., Nepom, Gerald T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007402/ https://www.ncbi.nlm.nih.gov/pubmed/24795433 http://dx.doi.org/10.1242/dmm.015099 |
Ejemplares similares
-
Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity
por: von Herrath, Matthias G., et al.
Publicado: (2005) -
Immunotherapeutic strategies in autoimmune uveitis
por: Papotto, Pedro Henrique, et al.
Publicado: (2014) -
Solving the puzzle of autoimmunity: critical questions
por: Smilek, Dawn E., et al.
Publicado: (2015) -
Immunotherapeutic Targeting in Autoimmune Diseases
por: Janikashvili, Nona, et al.
Publicado: (2016) -
Approaches to Establishing Tolerance in Immune Mediated Diseases
por: Huffaker, Michelle F., et al.
Publicado: (2021)